Atlas Trials

A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.

Clinical trial NCT07363707 · COMPLETED

Trial details

NCT number
NCT07363707
Sponsor
Beni-Suef University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
NAFLD (Nonalcoholic Fatty Liver Disease)
Start date
2023-05-01
Primary completion
2023-08-27
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.